Condensed Consolidated Statements of Cash Flows (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities
Net income (loss)	$ 93.9	$ (26.6)
Adjustments to reconcile net income (loss) to net cash provided by operating activities
Depreciation and amortization	168.6	127.6
Loss on extinguishment of debt	19.4	0
Provision for loss on receivables	8.2	9.0
Loss from CyrusOne equity method investment	1.9	8.1
Gain on sale of CyrusOne equity method investment	(192.8)	0
Asset impairment	7.5	0
Noncash portion of interest expense	4.8	5.7
Deferred income tax provision	57.8	1.9
Pension and other postretirement payments in excess of expense	(22.4)	(43.0)
Stock-based compensation	2.5	4.0
Amortization of deferred gain	(16.5)	(1.7)
(Gain) loss on sale or disposal of assets, net	(0.1)	2.6
Excess tax benefit for share based payments	(0.1)	(0.5)
Other, net	(1.1)	(0.4)
Changes in operating assets and liabilities, net of CyrusOne deconsolidation:
Increase in receivables	(35.9)	(4.4)
Increase in inventory, materials, supplies, prepaid expenses and other current assets	(2.7)	(6.7)
Increase (decrease) in accounts payable	19.5	(1.0)
Increase (decrease) in accrued and other current liabilities	13.8	(3.8)
Decrease in other noncurrent assets	1.3	0.1
Decrease in other noncurrent liabilities	(6.8)	(11.1)
Net cash provided by operating activities	120.8	59.8
Cash flows from investing activities
Capital expenditures	(121.1)	(142.0)
Proceeds from sale of CyrusOne equity method investment	355.9	0
Dividends received from CyrusOne	22.4	14.2
Proceeds from sale of Wireless spectrum licenses	194.4	0
Proceeds from sale of assets	2.0	1.8
Release of restricted cash	0	0.4
Cash divested from deconsolidation of CyrusOne	0	(12.2)
Other, net	(5.7)	0
Net cash provided by (used in) investing activities	447.9	(137.8)
Cash flows from financing activities
Proceeds from issuance of long-term debt	0	536.0
Net decrease in corporate credit and receivables facilities with initial maturities less than 90 days	(33.8)	(52.0)
Repayment of debt	(350.6)	(6.7)
Debt issuance costs	0	(6.4)
Dividends paid on preferred stock	(7.8)	(7.8)
Proceeds from exercise of options and warrants	1.2	6.8
Excess tax benefit for share based payments	0.1	0.5
Other, net	(0.9)	(2.3)
Net cash (used in) provided by financing activities	(391.8)	468.1
Net increase in cash and cash equivalents	176.9	390.1
Cash and cash equivalents at beginning of period	4.6	23.6
Cash and cash equivalents at end of period	181.5	413.7
Noncash investing and financing transactions:
Investment in CyrusOne resulting from deconsolidation	0	509.7
Accrual of CyrusOne dividends	6.0	7.1
Acquisition of property by assuming debt and other noncurrent liabilities	0.6	5.6
Acquisition of property on account	$ 42.0	$ 20.4